|
N
|
NOVARTIS GENE THERAPIES EU LIMITED ActiveScientific & Education |
Financial Statements of NOVARTIS GENE THERAPIES EU LIMITED
NOVARTIS GENE THERAPIES EU LIMITED submitted their latest company financial report on 2019-12-31 and shows a Turnover of €15M. The company’s Working-Capital is -€44,269.00, and the company’s Profit-after-Tax is -€66,845.00. In comparison to the previous year, the company reported an decrease in Turnover of 0.0%. This is equivalent to 15.2 million. The Working-Capital also went down by -44269 or 0.0%.
Turnover 2019
€ 15.2 million
-
Consolidated A/cs
0
-
Reporting period
-
-
Working Capital
€ -44269
-
Profit after Tax
€ -66845
NOVARTIS GENE THERAPIES EU LIMITED Business Credit Report
A Credit Report NOVARTIS GENE THERAPIES EU LIMITED is available for instant download. When we generate this report, we took into account that the company is 3 year old, Turnover €15M, Working-Capital -€44,269.00 and the Profit-after-Tax of -€66,845.00, we took into account if there are any outstanding mortgages or Court Judgements and checked if the industry which the company is trading, Research and experimental development on biotechnology, is considered a high level of corporate failures.
NOVARTIS GENE THERAPIES EU LIMITED
NOVARTIS GENE THERAPIES EU LIMITED Competitors List
View all competitorsThe key competitors of NOVARTIS GENE THERAPIES EU LIMITED are TES PHARMA S.R.L., KITHER BIOTECH S.R.L., THEMIS S.P.A., GLOMERIA THERAPEUTICS SOCIETA A RESPONSABILITA LIMITATA. To view, as well as export, the full competitor list for NOVARTIS GENE THERAPIES EU LIMITED, simply upgrade your account here.
TES PHARMA S.R.L.
KITHER BIOTECH S.R.L.
THEMIS S.P.A.
GLOMERIA THERAPEUTICS SOCIETA A RESPONSABILITA LIMITATA
NOVARTIS GENE THERAPIES EU LIMITED News & Activities
View full activityTurnover
New account statements were submitted by NOVARTIS GENE THERAPIES EU LIMITED. They reflect a turnover of €15M, which is a 0.0% increase year-over-year.
italy.globaldatabase.com
2019-12-31
{FAQ} Frequently Asked Questions for NOVARTIS GENE THERAPIES EU LIMITED
Where is NOVARTIS GENE THERAPIES EU LIMITED’s registered office located?
NOVARTIS GENE THERAPIES EU LIMITED’s registered office is located at: BLOCCO B,EDIFICIO THE CRESCENT, S.C, Italy.
How many employees does NOVARTIS GENE THERAPIES EU LIMITED have?
The company currently has 7 employees employed at NOVARTIS GENE THERAPIES EU LIMITED.
How much is the annual revenue of NOVARTIS GENE THERAPIES EU LIMITED?
Their latest financial accounts were submitted on 2019-12-31 and show that the company made €15M for 2019. This is an {increase/decrease} of 0.0%.
What is the business credit score of NOVARTIS GENE THERAPIES EU LIMITED? Is NOVARTIS GENE THERAPIES EU LIMITED a reliable company?
In order to view NOVARTIS GENE THERAPIES EU LIMITED’s business credit score, you will need to order a business credit report. This business credit report will show the company’s latest ownership, credit limit information, group structure, court judgements, and much more.
How will I know if NOVARTIS GENE THERAPIES EU LIMITED pays their invoices on time?
You can view the payment trends of NOVARTIS GENE THERAPIES EU LIMITED when you order a business credit report for NOVARTIS GENE THERAPIES EU LIMITED.
Search for International Credit Report
|
Name
|
City
|
Address
|
Reg. No
|
Status
|
Action |
|---|
